相似文献
1
Cell-based interventions for therapeutic angiogenesis: review of potential cell sources.
Vascular. 2012 Dec;20(6):360-8. doi: 10.1258/vasc.2011.201205. Epub 2012 Oct 19.
2
Stem cell therapy in PAD.
Eur J Vasc Endovasc Surg. 2010 Mar;39 Suppl 1:S38-43. doi: 10.1016/j.ejvs.2009.12.001. Epub 2010 Feb 12.
3
Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia.
Stem Cells Transl Med. 2017 Jan;6(1):261-271. doi: 10.5966/sctm.2015-0380. Epub 2016 Aug 15.
4
Therapeutic angiogenesis for critical limb ischemia.
Semin Vasc Surg. 2014 Mar;27(1):23-31. doi: 10.1053/j.semvascsurg.2014.10.001. Epub 2014 Oct 17.
5
Cell therapy in critical limb ischemia: current developments and future progress.
Cytotherapy. 2012 Sep;14(8):902-16. doi: 10.3109/14653249.2012.693156. Epub 2012 Jun 25.
6
Stem cell therapy for critical limb ischemia: what can we learn from cell therapy for chronic wounds?
Vascular. 2012 Oct;20(5):284-9. doi: 10.1258/vasc.2011.201206. Epub 2012 Oct 19.
7
Role of endothelial progenitor cells during ischemia-induced vasculogenesis and collateral formation.
Microvasc Res. 2010 May;79(3):200-6. doi: 10.1016/j.mvr.2010.01.012. Epub 2010 Feb 6.
8
Pro-angiogenic cell-based therapy for the treatment of ischemic cardiovascular diseases.
Thromb Res. 2012 Oct;130 Suppl 1:S90-4. doi: 10.1016/j.thromres.2012.08.287.
9
Current Status of Angiogenic Cell Therapy and Related Strategies Applied in Critical Limb Ischemia.
Int J Mol Sci. 2021 Feb 26;22(5):2335. doi: 10.3390/ijms22052335.
10
Endothelial progenitor cells as a therapeutic option in peripheral arterial disease.
Eur J Vasc Endovasc Surg. 2009 Oct;38(4):475-81. doi: 10.1016/j.ejvs.2009.05.019. Epub 2009 Jun 27.
引用本文的文献
1
De novo copy number variations in candidate genomic regions in patients of severe autism spectrum disorder in Vietnam.
PLoS One. 2024 Mar 7;19(3):e0290936. doi: 10.1371/journal.pone.0290936. eCollection 2024.
2
CD34-Structure, Functions and Relationship with Cancer Stem Cells.
Medicina (Kaunas). 2023 May 12;59(5):938. doi: 10.3390/medicina59050938.
3
Supramolecular hydrogels encapsulating bioengineered mesenchymal stem cells for ischemic therapy.
RSC Adv. 2018 May 22;8(34):18771-18775. doi: 10.1039/c8ra00464a.
4
CD34 circulating cells display signs of immune activation in patients with acute coronary syndrome.
Heart Vessels. 2018 Dec;33(12):1559-1569. doi: 10.1007/s00380-018-1220-7. Epub 2018 Jul 12.
5
A Murine Model of Hind Limb Ischemia to Study Angiogenesis and Arteriogenesis.
Methods Mol Biol. 2018;1717:135-143. doi: 10.1007/978-1-4939-7526-6_11.
6
An open-label proof-of-concept study of intrathecal autologous bone marrow mononuclear cell transplantation in intellectual disability.
Stem Cell Res Ther. 2018 Jan 31;9(1):19. doi: 10.1186/s13287-017-0748-2.
7
Biological therapies in otology.
HNO. 2017 Aug;65(Suppl 2):87-97. doi: 10.1007/s00106-016-0306-8.
8
[Biological therapies in otology. German version].
HNO. 2017 Jul;65(7):571-585. doi: 10.1007/s00106-016-0304-x.
9
Biohybrid cochlear implants in human neurosensory restoration.
Stem Cell Res Ther. 2016 Oct 7;7(1):148. doi: 10.1186/s13287-016-0408-y.
10
Hypoxia-inducible factor as an angiogenic master switch.
Front Pediatr. 2015 Apr 24;3:33. doi: 10.3389/fped.2015.00033. eCollection 2015.
本文引用的文献
1
Endothelial progenitor cells as therapeutic agents in the microcirculation: an update.
Atherosclerosis. 2011 Mar;215(1):9-22. doi: 10.1016/j.atherosclerosis.2010.10.039. Epub 2010 Nov 3.
2
Combination stem cell therapy for the treatment of severe limb ischemia: safety and efficacy analysis.
Angiology. 2010 Aug;61(6):551-6. doi: 10.1177/0003319710364213. Epub 2010 May 24.
3
Development of monocytes, macrophages, and dendritic cells.
Science. 2010 Feb 5;327(5966):656-61. doi: 10.1126/science.1178331.
4
Elevated monocytes in patients with critical limb ischemia diminish after bypass surgery.
J Surg Res. 2011 May 1;167(1):140-50. doi: 10.1016/j.jss.2009.06.014. Epub 2009 Jul 12.
5
Characterization and comparison of bone marrow and peripheral blood mononuclear cells used for cellular therapy in critical leg ischaemia: towards a new cellular product.
Vox Sang. 2009 Apr;96(3):256-65. doi: 10.1111/j.1423-0410.2008.01138.x. Epub 2008 Dec 15.
6
Blood monocytes: development, heterogeneity, and relationship with dendritic cells.
Annu Rev Immunol. 2009;27:669-92. doi: 10.1146/annurev.immunol.021908.132557.
7
Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers.
Histochem Cell Biol. 2009 Feb;131(2):267-82. doi: 10.1007/s00418-008-0519-3. Epub 2008 Oct 3.
8
Long-term propagation of distinct hematopoietic differentiation programs in vivo.
Cell Stem Cell. 2007 Aug 16;1(2):218-29. doi: 10.1016/j.stem.2007.05.015.
9
New insights on endothelial progenitor cell subpopulations and their angiogenic properties.
J Am Coll Cardiol. 2008 Feb 12;51(6):669-71. doi: 10.1016/j.jacc.2007.09.057.
10
Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay.
J Am Coll Cardiol. 2008 Feb 12;51(6):660-8. doi: 10.1016/j.jacc.2007.09.059.
Zotero 插件